Subsequent analyses of immunohistochemically labelled NGF, BDNF, TrkA, and TrkB proteins in a set of seven tumor samples from seven patients with ES revealed heterogenous expression of these proteins across tumor samples (Figure 1C–1G). This evidence concerns the gene NTRK1 and neoplasm.